Royal Bank of Canada’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-26,000
Closed -$4.38M 7593
2023
Q1
$4.38M Buy
+26,000
New +$4.64M ﹤0.01% 2177
2014
Q3
Sell
-70,000
Closed -$1.59M 6095
2014
Q2
$1.59M Buy
+70,000
New +$1.25M ﹤0.01% 2468

Other funds holding RGEN

Royal Bank of Canada's RGEN Position: Q1 2026 in Review

Royal Bank of Canada increased its Repligen (RGEN) stake by 4.6% in Q1 2026, buying an estimated $919K and bringing the position to 149,903 shares worth $17.7M. The position accounts for ﹤0.01% of the portfolio, ranked #1529.

Royal Bank of Canada first reported a position in RGEN in Q2 2013 and has held it in 52 quarters since. The position peaked at $32.1M in Q3 2025. 443 funds tracked by Wall St. Rank hold RGEN as of Q1 2026.

  • Royal Bank of Canada held 149,903 shares of Repligen worth $17.7M as of Q1 2026.
  • Royal Bank of Canada bought 6,577 Repligen shares in Q1 2026, an estimated $919K.
  • Repligen made up ﹤0.01% of Royal Bank of Canada's portfolio in Q1 2026, its #1529 holding.
  • Royal Bank of Canada first reported a position in Repligen in Q2 2013 and has held it in 52 quarters since.
  • Royal Bank of Canada's Repligen position peaked at $32.1M in Q3 2025.
  • 443 funds tracked by Wall St. Rank held Repligen as of Q1 2026.

Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.